Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advanced Diffusion Imaging in Renal Cancer Patients
NCT06116253Active, not recruiting
- Sponsor
- NYU Langone Health
- Start
- Dec 2022
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by NYU Langone Health. Primary endpoint: Percentage of Times Lesion Type is Correctly Predicted using IVIM-MRI. Started Dec 2022; status: active, not recruiting.
Beyond the preview
Go deeper on NCT06116253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06116253.